ERBB2 and cancer: PHLDA1inhibits ErbB receptor, particularly ERBB2,3 oligomerization, to suppress its down-stream signaling [48], and also modulates the cell susceptibility to apoptosis via the endoplasmic reticulum stress response pathway in the cancer setting [49].